Therapy of HIV-associated Kaposi's sarcoma
Plettenberg, A.
Zeitschrift für Arztliche Fortbildung 85(23): 1150-1152
1991
ISSN/ISBN: 0044-2178 PMID: 1723230 Document Number: 376628
Document emailed within 1 workday
Related Documents
Warmuth, I.; Moore, P.S. 1997: Kaposi sarcoma, Kaposi sarcoma-associated herpesvirus, and human T-cell lymphotropic virus type 1. what is the current evidence for causality? Archives of Dermatology 133(1): 83-85Olsen, S.J.; Chang, Y.; Moore, P.S.; Biggar, R.J.; Melbye, M. 1998: Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985 Aids 12(14): 1921-1925
Simonart, T.; Dobbeleer, G.D.; Peny, M.; Fayt, I.; Parent, D.; Vooren, J.; Noel, J. 1999: Pre-Kaposi's sarcoma: an expansion of the spectrum of Kaposi's sarcoma lesions European Journal of Dermatology: Ejd 9(6): 480-482
Huang, K.-M.; Hsu, C.-H.; Cheng, J.C.-H.; Lai, M.-K.; Jeng, S.-C.; Ting, L.-L.; Huang, W.-T. 2006: Radiotherapy of classic Kaposi's sarcoma in Taiwan, an area where classic Kaposi's sarcoma is not prevalent Anticancer Research 26(6c): 4659-4663
Reinfuss, M. 1987: Kaposi's sarcoma. Clinical picture, treatment and prognosis. I. Clinical forms of Kaposi's sarcoma Nowotwory 37(3): 195-206
Murakami-Mori, K.; Mori, S.; Taga, T.; Kishimoto, T.; Nakamura, S. 1997: Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation Journal of Immunology 158(11): 5518-5526
Abrams, D.I.; Volberding, P.A. 1987: Alpha interferon therapy of AIDS-associated Kaposi's sarcoma Seminars in Oncology 14(2 Suppl 2: 43-47
Krown, S.E. 1987: The role of interferon in the therapy of epidemic Kaposi's sarcoma Seminars in Oncology 14(2 Suppl 3: 27-33
Akmal, S.N.; Wahab, Y.A. 1989: Kaposi's sarcoma following long term steroid therapy Malaysian Journal of Pathology 11: 65-68
Holland, J.C.; Tross, S. 1987: Psychosocial considerations in the therapy of epidemic Kaposi's sarcoma Seminars in Oncology 14(2 Suppl 3: 48-53
Murakami-Mori, K.; Mori, S.; Bonavida, B.; Nakamura, S. 1999: Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells Journal of Immunology 162(6): 3672-3679
Plettenberg, A.; Janik, I.; Kolb, H.; Meigel, W. 1991: Local therapy measures in HIV-associated Kaposi's sarcoma with special reference to fractionation radiotherapy Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 167(4): 208-213
Roszkiewicz, A.; Roszkiewicz, J.; Lange, M.; Tukaj, C. 1998: Kaposi's sarcoma following long-term immunosuppressive therapy: clinical, histologic, and ultrastructural study Cutis 61(3): 137-141; Quiz 152
Borleffs, J.C.; Hoepelman, I.M.; van der Ende, M.E.; van Leusen, R.; van 't Wout, J.W. 1991: Triple therapy with vinblastine, interferon-alpha 2a and zidovudine for AIDS-related Kaposi's sarcoma Journal of Acquired Immune Deficiency Syndromes 4(11): 1161-1162
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Herce, M.E.; Kalanga, N.; Wroe, E.B.; Keck, J.W.; Chingoli, F.; Tengatenga, L.; Gopal, S.; Phiri, A.; Mailosi, B.; Bazile, J.; Beste, J.A.; Elmore, S.N.; Crocker, J.T.; Rigodon, J. 2015: Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi Journal of the International Aids Society 18: 19929
Kalamkarian, A.A. 1988: Principles of the current therapy of malignant lymphomas of the skin (mycosis fungoides, primary reticulosis, reticulosarcomatosis of the skin) and Kaposi's sarcoma Vestnik Dermatologii i Venerologii 2: 4-10
Ognibene, F.P.; Shelhamer, J.H. 1988: Kaposi's sarcoma Clinics in Chest Medicine 9(3): 459-465
De Scoville, A. 1973: Kaposi's sarcoma Minerva Chirurgica 28(11): 862-865